Annual Meeting 2013 - CALGB 40601 - Dr. Lisa Carey

Description: For more updates visit

Dr. Lisa Carey presenting the results of Abstract #500: Clinical and translational results of CALGB 40601: A neoadjuvant phase III trial of weekly paclitaxel and trastuzumab with or without lapatinib for HER2-positive breast cancer.
Shared By : oncologyeducation
Posted on : 06/23/13
Added : 6 years ago
Category : Breast Cancer